Delivery Order SPE2DB20D1100-SPE2DB24FB4K1
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,611.14, is a delivery order for the supply of COSENTYX SENSOREADY 150 MG PENML. The contract has an ultimate completion date of January 24, 2025 and is a firm fixed-price contract. No set-aside designation was used for this award. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This federal contract award, valued at $14,136.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the provision of COSENTYX SENSOREADY 150 MG PENML, a pharmaceutical product. The contract has an ultimate completion date of April 28, 2025 and is a firm fixed-price contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $3,043.90 firm fixed-price delivery order is for the supply of COSENTYX SENSOREADY 150 MG PEN medication and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 2025. This IDC serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $15,710.80, is for the delivery of COSENTYX SENSOREADY 150 MG PEN ML, a specialty pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of August 21, 2024. The contract does not have a set-aside designation. AmerisourceBergen, through its Corporate Office division,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The award, with a ceiling value of $3,879.78, is for the delivery of COSENTYX SENSOREADY 150 MG PEN medication and has a completion date of June 24, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA to provide a comprehensive range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,642.44 Firm Fixed Price Delivery Order is for the supply of COSENTYX SENSOREADY 150 MG PEN ML medication. The contract has an ultimate completion date of April 9, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $16,221.56 firm-fixed-price delivery order is for the supply of COSENTYX SENSOREADY 150 MG PEN injections, with a period of performance through May 13, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor. The $5,871.99 Delivery Order contract is for the provision of COSENTYX SENSOREADY 150 MG PEN/ML, a prescription medication, with a completion date of May 9, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with both the DLA and the Department of Justice Federal Bureau of Investigation,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,016.23 firm fixed-price contract is for the supply of COSENTYX SENSOREADY 150 MG PENML, a specialty medication. The contract has an ultimate completion date of May 31, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of 4,565,940,082 units of COSENTYX SENSOREADY 150 MG PENML, which are pharmaceutical products used in medical treatment. The contract has a ceiling value of $33,138.89 and is a Firm Fixed Price Delivery Order contract, with a completion date of September 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FB4K1Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $11,201.67 Firm Fixed Price Delivery Order contract is for the provision of 4,564,388,122 units of the COSENTYX SENSOREADY 150 MG PEN for the U.S. government. The contract has an ultimate completion date of April 25, 2024. AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025. This IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC valued up to $750,000 with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs through May 2024. This contract award was not set aside for any specific business designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 4/24/24 |